Xuelian J. Xiong

180 Fenlin Road
Xuhui, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Endocrinologist at a crossroads: professional obsolescence challenged by artificial intelligence.

Endocrinologist at a crossroads: professional obsolescence challenged by artificial intelligence.

Journal: Precision clinical medicine

Published: November 04, 2025

Metabolic reprogramming drives pancreatic β cell neogenesis from α cells.

Metabolic reprogramming drives pancreatic β cell neogenesis from α cells.

Journal: Nature chemical biology

Published: September 24, 2025

Metabolic dysfunction-associated steatohepatitis exacerbated by Clostridium perfringens-derived ammonia is attenuated by tripeptide DT-109.

Metabolic dysfunction-associated steatohepatitis exacerbated by Clostridium perfringens-derived ammonia is attenuated by tripeptide DT-109.

Journal: The Journal of clinical investigation

Published: September 23, 2025

GDF10 attenuates MASH progression by restoring quiescent hepatic stellate cells via competitive inhibition of TGF-β/SMAD2 signaling.

GDF10 attenuates MASH progression by restoring quiescent hepatic stellate cells via competitive inhibition of TGF-β/SMAD2 signaling.

Journal: International journal of biological sciences

Published: August 15, 2025

Autocrine Netrin-1 Signaling in Hepatic Stellate Cells Drives Liver Fibrosis and Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis in Mice.

Autocrine Netrin-1 Signaling in Hepatic Stellate Cells Drives Liver Fibrosis and Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis in Mice.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 31, 2025

Dietary vitamin E intake is associated with lower mortality among individuals with metabolic dysfunction-associated steatotic liver disease.

Dietary vitamin E intake is associated with lower mortality among individuals with metabolic dysfunction-associated steatotic liver disease.

Journal: Nutrition research (New York, N.Y.)

Published: June 22, 2025

Letter to the Editor: Considerations on the diagnostic accuracy and applicability of MASHResInd in MASH resolution.

Letter to the Editor: Considerations on the diagnostic accuracy and applicability of MASHResInd in MASH resolution.

Journal: Hepatology (Baltimore, Md.)

Published: June 16, 2025

Development and Validation of a Nocturnal Hypoglycaemia Risk Model for Patients With Type 2 Diabetes Mellitus.

Development and Validation of a Nocturnal Hypoglycaemia Risk Model for Patients With Type 2 Diabetes Mellitus.

Journal: Nursing open

Published: January 22, 2024

Editorial: Secreted proteins as novel biomarkers and therapeutic targets in NAFLD.

Editorial: Secreted proteins as novel biomarkers and therapeutic targets in NAFLD.

Journal: Frontiers in endocrinology

Published: August 14, 2023

Regulation of Atherosclerosis Development by Neurotensin Derived From Lymphatic Endothelial Cells in Mice.

Regulation of Atherosclerosis Development by Neurotensin Derived From Lymphatic Endothelial Cells in Mice.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: August 03, 2023

Applying proteomics in metabolic dysfunction-associated steatotic liver disease: From mechanism to biomarkers.

Applying proteomics in metabolic dysfunction-associated steatotic liver disease: From mechanism to biomarkers.

Journal: Clinics and research in hepatology and gastroenterology

Published: July 31, 2023

Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology.

Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology.

Journal: Frontiers in endocrinology

Published: February 08, 2023

Showing 1-12 of 44

Last Updated: 09/26/2026